Actively Recruiting

Age: 18Years - 85Years
All Genders
NCT06120270

CeraFlex PFO Closure System PMCF Study

Led by Lifetech Scientific (Shenzhen) Co., Ltd. · Updated on 2026-01-26

180

Participants Needed

15

Research Sites

265 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The purpose of this study is to compile real-world data on patient outcomes and evaluate the procedural success and performance of the CeraFlex™ PFO Closure System.

CONDITIONS

Official Title

CeraFlex PFO Closure System PMCF Study

Who Can Participate

Age: 18Years - 85Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Confirmed Patent Foramen Ovale (PFO) by medical examinations
  • Indication for PFO occluder closure based on recurrent migraine/headache, transient ischemic attack (TIA), or cryptogenic stroke
  • Patient characteristics matching the device instructions for use and appropriate device size selection
  • Willingness to comply with all study procedures and availability for the study duration
  • Ability to provide informed consent by the patient or legally authorized representative
Not Eligible

You will not qualify if you...

  • Age under 18 years or over 85 years
  • History of ongoing atrial fibrillation (AF)
  • Malignancy or illness with life expectancy less than 1 year
  • Not covered by a social security scheme
  • Currently participating in another investigational drug or device study
  • Women of childbearing potential who are pregnant or plan to become pregnant during the study
  • Any condition increasing risk or preventing full compliance with the study
  • Contraindications from the device instructions for use, including intracardiac thrombi, bleeding disorders untreated for aspirin therapy, unsuitable anatomy interfering with device placement, inability to undergo catheterization, active infection, recent sepsis, insufficient heart tissue for device placement, hypercoagulation disease, or device size exceeding anatomical limits

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 15 locations

1

Kardiologisch-Angiologische Praxis - Herzzentrum Bremen

Bremen, Germany

Actively Recruiting

2

Heart Center Dresden

Dresden, Germany

Not Yet Recruiting

3

Hospital Fürth

Fürth, Germany

Actively Recruiting

4

Kath. Marienkrankenhaus gGmbH

Hamburg, Germany

Actively Recruiting

5

Universitätsklinikum Hamburg-Eppendorf (UKE)

Hamburg, Germany

Actively Recruiting

6

German Heart Center Leipzig

Leipzig, Germany

Actively Recruiting

7

Klinikum St. Georg gGmbH Leipzig

Leipzig, Germany

Not Yet Recruiting

8

German Heart Center Munich

Munich, Germany

Actively Recruiting

9

Herzzentrum Trier

Trier, Germany

Actively Recruiting

10

University clinic Tübingen

Tübingen, Germany

Actively Recruiting

11

Yeungnam University Medical Center

Daegu, South Korea

Not Yet Recruiting

12

Chonnam National University Hospital

Gwangju, South Korea

Not Yet Recruiting

13

ASAN Medical Center

Seoul, South Korea

Not Yet Recruiting

14

Samsung Medical Center

Seoul, South Korea

Not Yet Recruiting

15

Catholic University of Korea St. Vincent's Hospital

Suwon, South Korea

Not Yet Recruiting

Loading map...

Research Team

K

Kadir Shemsi, CTM

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here